| Composition | Ceftriaxone 1000mg Tazobactam 125mg |
|---|---|
| Dosage | VIAL |
| Packing Size | 25 x 1.125gm |
| Packing | Vial with wfi |
CIFAN TZ 1.125 Injection is a trusted antibiotic combination specially formulated to combat a wide range of bacterial infections with high effectiveness. It contains ceftriaxone and tazobactam, a synergistic pair that delivers strong antibacterial action and provides reliable results in resistant cases. Belonging to the advanced injectable range, CIFAN TZ 1.125 Injection is widely used in hospitals and clinics where rapid response and consistent outcomes are critical.
CIFAN TZ 1.125 Injection is made with 1g of ceftriaxone and 125mg of tazobactam, ensuring enhanced spectrum activity. Ceftriaxone, a third-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, while tazobactam acts as a beta-lactamase inhibitor to prevent resistance. This combination ensures maximum efficacy against both gram-positive and gram-negative organisms. With its injectable form, CIFAN TZ 1.125 guarantees quick onset of action and direct therapeutic impact.
CIFAN TZ 1.125 Injection is highly effective in treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, and post-surgical infections. It is particularly useful in critical and emergency care where fast infection control is required. Patients benefit from quicker recovery, improved outcomes, and reduced risk of complications.
Choosing CIFAN TZ 1.125 Injection means opting for a broad-spectrum, safe, and clinically proven antibiotic therapy. Healthcare professionals trust it for its consistent performance, patient safety, and ability to manage resistant infections effectively. With its powerful formulation and wide clinical use, CIFAN TZ 1.125 Injection is a preferred choice in hospitals and specialty care.
CIFAN TZ 1.125 Injection is the right solution for effective, reliable, and result-oriented treatment of serious bacterial infections.
